The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1448
August 4, 2014
View Complete Issue         Table of Contents 2019 
Drugs for Inflammatory Bowel Disease
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Drugs for Inflammatory Bowel Disease
August 4, 2014 (Issue: 1448)
Aminosalicylates are effective for induction and maintenance of remission in mild to moderate ulcerative colitis. They are not recommended for treatment of Crohn's disease. FORMULATIONS — Oral mesalamine is rapidly absorbed in the small...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Inflammatory Bowel Disease
Article code: 1448a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.